These results are in line with several in vitro and animal investigations showing that, while the baseline LOX-1 expression is low in healthy endothelium, hypertension [31], hyperglycemia [32], and dyslipidemia [33] have been reported to increase it. Here, OLR1 is linked to metabolic syndrome.